Stay updated on Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial

Sign up to get notified when there's something new on the Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Record History now includes added sections for Adverse Events, Outcome Measures, Participant Flow, and References. A new version entry dated 2026-05-12 indicates updated content in the study record.
    Difference
    0.8%
    Check dated 2026-05-16T09:21:17.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page’s revision/version indicator was updated from **v3.5.2** to **v3.5.3**, reflecting a site or interface release rather than substantive trial-record changes.
    Difference
    0.1%
    Check dated 2026-04-24T22:26:09.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Added revision v3.5.2 and removed revision v3.5.0 from the study record history.
    Difference
    0.1%
    Check dated 2026-04-17T14:17:48.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    A new revision entry v3.5.0 has been added and the previous entry v3.4.3 has been removed.
    Difference
    0.1%
    Check dated 2026-03-19T23:29:56.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Added revision v3.4.3 and removed revision v3.4.2 in the record history.
    Difference
    0.1%
    Check dated 2026-03-12T18:38:51.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The new screenshot shows a visual/UI refresh while the version history details remain the same; no substantive changes to study records are evident.
    Difference
    0.1%
    Check dated 2026-02-26T15:22:04.000Z thumbnail image

Stay in the know with updates to Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial page.